Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Edge Microbials is Australia’s leading producer of biofertilisers and biostimulants based on beneficial microbes. Their products are widely used to improve soil health, increase crop yields, reduce reliance on synthetic fertilisers, and support sustainable agriculture. The company holds a dominant market share in Australia’s legume inoculant sector (~45–65%), with growing exports to Europe, North America, South America, Africa, and New Zealand. NEM’s partnership with Lallemand Plant Care expands its R&D pipeline and product range. The company also develops microbial solutions for industrial/agricultural/aquaculture waste bioremediation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Edge Microbials.